Clin2
NCT06879483Likely a fitNot yet recruiting

Thoraco-laparoscopic surgery for esophageal cancer

Esophageal Cancer

Part of Cancer, Digestive system clinical trials.

This trial tests a minimally invasive surgery to remove part of the esophagus and stomach for esophageal cancer. It may help people whose cancer has not spread and who are healthy enough for this procedure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with esophageal cancer that can be removed by surgery (stages I to III).
  • Your doctor has said you are suitable for this specific type of minimally invasive surgery.
  • You are in generally good health, able to care for yourself and do daily activities (ECOG score 0-2).
  • You do not have cancer that has spread to other parts of the body (no distant metastasis).
  • You have not had any previous surgery on your esophagus or stomach.
  • You do not have any medical reason that would prevent you from having laparoscopic or thoracoscopic surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05105945Not yet recruiting
New esophagus cancer surgery approach using single-port tools

This study tests a specific, minimally invasive surgery plan for removing esophagus cancer. It may help by reducing invasiveness while still aiming for a “radical” cancer removal after the right kind of prior treatment.

Zhuhai, Guangdong
NCT06586242Recruiting· Phase 2
Penpulimab, anlotinib, and chemo before surgery for esophageal cancer

This trial tests a combination of three drugs (penpulimab, anlotinib, and chemotherapy) given before surgery to shrink esophageal cancer. It is for people with locally advanced cancer who have not had treatment before.

Xi'an, Shaan'xi
NCT06668454Recruiting
Chemoimmunotherapy before surgery for limited spread esophageal cancer

This trial tests a treatment plan that combines chemotherapy with immunotherapy, followed by surgery, for people whose esophageal or stomach cancer has spread to a few areas (oligometastatic). The goal is to see if this approach can shrink the cancer and improve outcomes.

Toronto, Ontario
NCT03385018Recruiting
Laparoscopic total stomach surgery trial for stomach cancer

This trial studies whether a minimally invasive (laparoscopic) removal of the entire stomach, along with lymph node removal, can be done safely and effectively for certain stomach cancers. It may be an option if your cancer is in the stomach, has limited spread to nearby lymph nodes, and can be fully removed.

Seoul
NCT06679244Recruiting
New surgery for upper stomach cancer

This trial tests a new surgical technique for patients with cancer in the upper part of the stomach or where the stomach meets the esophagus. It aims to see if the new approach is safe and effective for removing the tumor and nearby lymph nodes.

Shanghai
NCT04295473Recruiting
Test of smaller-incision stomach surgery for gastric cancer

This trial studies a stomach cancer surgery done with fewer/smaller incisions (laparoscopic with reduced ports). It may help people with certain early-to-mid stage stomach cancers by comparing whether this approach is safe and effective for them.

Nanchong, Sichuan

Hear when a new Esophageal Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.